Home/Filings/4/0001209191-17-036145
4//SEC Filing

Sierra Oncology, Inc. 4

Accession 0001209191-17-036145

CIK 0001290149operating

Filed

May 29, 8:00 PM ET

Accepted

May 30, 4:44 PM ET

Size

5.7 KB

Accession

0001209191-17-036145

Insider Transaction Report

Form 4
Period: 2017-05-25
ESTES DANIEL
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-05-25+50,00050,000 total
    Exercise: $1.20Exp: 2027-05-25Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Stock options were granted in connection with the reporting person's appointment to the issuer's board of directors on April 10, 2017.
  • [F2]The option vests as to 8.333% of the total shares monthly, beginning on June 25, 2017, with 100% of the total shares vested and exercisable on May 25, 2018, subject to the reporting person's provision of service to the issuer on each vesting date.

Issuer

Sierra Oncology, Inc.

CIK 0001290149

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001290149

Filing Metadata

Form type
4
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:44 PM ET
Size
5.7 KB